ClinicalTrials.gov
public full text
Public Domain
PACAP38 Induced Headache, Migraine and Flushing in Patients With Migraine
The aim is to investigate the incidence of headache, migraine attacks and flushing after pituitary adenylate cyclase-activating peptide-38 (PACAP38) with and without treatment with sumatriptan in patients with migraine
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Rizatriptan in Acute Treatment of Migraine in Patients With Unilateral Trigeminal-autonomic Symptoms.#905609
- Migraine Induction Properties of PACAP-38 After Eptinezumab in Migraine Without Aura Patients.#1172434
- No Change in Interictal PACAP Levels in Peripheral Blood in Women With Chronic Migraine#947627
- Hypersensitivity to PACAP-38 in Post-Traumatic Headache#966639
- Effects of Sumatriptan on PACAP, PAC-1, CGRP, VIP, and TRPV-1 Molecules in an Experimental Migraine Model#261134
Record · ID 801835
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive